Varvoutis Megan S, Abdalla Azza E, Dotters-Katz Sarah K
Department of OB/GYN, West Virginia University, Morgantown, West Virginia.
Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Duke University, Durham, North Carolina.
AJP Rep. 2022 Feb 4;12(1):e58-e63. doi: 10.1055/s-0041-1742269. eCollection 2022 Jan.
The effect of the degree of maternal fever in the setting of chorioamnionitis on neonatal morbidity is unclear. The objective of this study is to assess the association between high maternal fevers (≥ 39°C) on neonatal morbidity. Secondary analysis of Maternal-Fetal Medicine Units (MFMU) Cesarean Registry data obtained from 1999 to 2002 among singleton gestations with chorioamnionitis. Women with a temperature less than 39°C (low fever) compared with those with greater than or equal to 39°C (high fever). Primary outcome was a composite of adverse neonatal outcomes such as death, sepsis, necrotizing enterocolitis, grade-3 or -4 intraventricular hemorrhage, seizure within 24 hours of delivery, intubation within 24 hours of delivery, and requiring cardiopulmonary resuscitation. Demographic characteristics compared using Fisher's exact and Wilcoxon's rank-sum test as appropriate. Multivariate logistic regression analysis with performed to control for cofounders. Stratified analysis also performed to assess outcomes in term infants. Of 1,313 included women, 1,200 (91.3%) were in the low fever group and 113 (8.7%) were in the high fever group. Women in the high fever group were more likely to be African American and group B positive. No difference in primary outcome was noted between the groups (38.9% high fever vs. 35.8% low fever, = 0.54). High maternal fever was associated with increased risk of NICU admission (48.1 vs. 50.4%, = 0.02). When controlling for African American race, preterm birth, and delivery route, patients with high fever were not more likely to have adverse neonatal outcomes (adjusted odds ratio [aOR] = 1.28, 95% confidence interval [CI]: 0.84, 1.98). In the analysis limited to term infants, when controlling for confounders, high fever, similarly, was not associated with increased odds of adverse neonatal outcomes (aOR = 1.59, 95% CI: 0.96, 2.65). The degree of maternal fever does not appear to be associated with an increased likelihood of adverse neonatal outcomes. Better understanding maternal factors that affect neonatal morbidity in the setting of chorioamnionitis is critical. High maternal fever in the setting of chorioamnionitis does not appear to have an increased likelihood of adverse neonatal outcomes.It is important to identify factors that may increase the risk of adverse outcomes such as early onset sepsis.Maternal fever may not be a strong indicator for neonatal outcomes and antibiotic protocols.
绒毛膜羊膜炎时母体发热程度对新生儿发病率的影响尚不清楚。本研究的目的是评估母体高热(≥39°C)与新生儿发病率之间的关联。
对1999年至2002年间从母婴医学单位(MFMU)剖宫产登记数据中获取的单胎妊娠合并绒毛膜羊膜炎的资料进行二次分析。将体温低于39°C(低热)的女性与体温大于或等于39°C(高热)的女性进行比较。主要结局是一系列不良新生儿结局的综合指标,如死亡、败血症、坏死性小肠结肠炎、3级或4级脑室内出血、出生后24小时内惊厥、出生后24小时内插管以及需要心肺复苏。根据情况使用Fisher精确检验和Wilcoxon秩和检验比较人口统计学特征。进行多因素逻辑回归分析以控制混杂因素。还进行了分层分析以评估足月儿的结局。
在纳入的1313名女性中,1200名(91.3%)属于低热组,113名(8.7%)属于高热组。高热组女性更可能是非裔美国人且B族链球菌阳性。两组之间在主要结局方面未发现差异(高热组为38.9%,低热组为35.8%,P = 0.54)。母体高热与新生儿重症监护病房(NICU)收治风险增加相关(分别为48.1%和50.4%,P = 0.02)。在控制非裔美国人种族、早产和分娩方式后,高热患者发生不良新生儿结局的可能性并未增加(校正优势比[aOR]=1.28,95%置信区间[CI]:0.84,1.98)。在仅限于足月儿的分析中,在控制混杂因素后,同样地,高热与不良新生儿结局的优势比增加无关(aOR = 1.59,95%CI:0.96,2.65)。
母体发热程度似乎与不良新生儿结局的可能性增加无关。更好地了解影响绒毛膜羊膜炎时新生儿发病率的母体因素至关重要。绒毛膜羊膜炎时母体高热似乎并未增加不良新生儿结局的可能性。识别可能增加不良结局风险的因素很重要,如早发型败血症。母体发热可能不是新生儿结局和抗生素治疗方案的有力指标。